Weight loss over two years predicts reduced diabetes risk

July 22, 2014
Weight loss over two years predicts reduced diabetes risk

(HealthDay)—Weight loss over two years is associated with reduced diabetes incidence and improvement in cardiometabolic risk factors, according to a study published online July 14 in Diabetes Care.

Linda M. Delahanty, R.D., from Massachusetts General Hospital in Boston, and colleagues examined measures of in relation to incident and cardiometabolic risk factors. Data were collected for 1,000 participants in the Diabetes Prevention Program lifestyle intervention arm. They analyzed nine measures, characterizing baseline weight, short- versus long-term weight loss, short- versus long-term weight regain, and weight cycling. The authors sought to examine predictors of incident diabetes and improvement in cardiometabolic risk factors.

The researchers found that weight loss in the first six months was protective of diabetes (hazard ratio, 0.94 per kg; P < 0.01) and cardiometabolic risk factors (P < 0.01); however, long-term weight loss (from zero to two years) was the strongest predictor of decreased incidence of diabetes (hazard ratio, 0.90 per kg; P < 0.01) and cardiometabolic risk factor improvement (for example, fasting glucose; P < 0.01). Per participant, weight cycling ranged from zero to six times and correlated positively with incident diabetes (hazard ratio, 1.33; P < 0.01), fasting glucose (P = 0.02), homeostatic model assessment insulin resistance (P = 0.04), and systolic blood pressure (P = 0.01). The effect of weight cycling was significant for diabetes risk (hazard ratio, 1.22; P = 0.03), but not for cardiometabolic traits, after adjustment for baseline weight.

"Two-year weight loss was the strongest predictor of reduced and improvements in cardiometabolic traits," the authors write.

Pharmaceutical, nutrition, and exercise industries donated materials, equipment, or medicines and/or supported the study.

Explore further: Intensive lifestyle changes lead to lasting improvement in T2DM

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Intensive lifestyle changes lead to lasting improvement in T2DM

June 2, 2014
(HealthDay)—For obese/overweight adults with type 2 diabetes, an intensive lifestyle intervention (ILI) is associated with a reduced risk of incident depression and with better physical function, according to a study published ...

Maintaining weight loss as important as losing it for older women

December 10, 2012
When you're postmenopausal and overweight, losing weight is a good thing, but gaining back just a few pounds may actually be detrimental to your cardiovascular health.

Nonalcoholic fatty liver disease linked to CKD in T1DM

April 9, 2014
(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published online April 2 in ...

Liraglutide augments weight loss in pre-type 2 diabetes

August 15, 2013
(HealthDay)—For patients at high risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), liraglutide in additional to calorie restriction is associated with more weight loss and improvements in insulin ...

Insulin resistance ups T2D risk, independent of BMI

July 7, 2014
(HealthDay)—A genetic score for insulin resistance is associated with lower body mass index (BMI) and with incident type 2 diabetes (T2D) even among individuals of normal weight, according to a study published online June ...

Phentermine, topiramate reduce progression to T2DM

October 21, 2013
(HealthDay)—Over two years, phentermine and topiramate extended-release (PHEN/TPM ER) treatment plus lifestyle changes lead to significant weight loss and a considerable reduction in progression to type 2 diabetes in high-risk, ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.